GlaxoSmithKline (GSK) Extends Asia Push with $109.5 Million Dong-A Pharmaceutical Co., Ltd. Alliance
5/11/2010 8:08:09 AM
More...
|
Warner Chilcott and Dong-A Pharmaceutical Co., Ltd. Sign U.S. License Agreement For Erectile Dysfunction Treatment
1/7/2009 8:04:25 AM
More...
|
Dong-A Pharmaceutical Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil
2/25/2008 8:27:31 AM
More...
|
Dong-A Pharmaceutical Co., Ltd. Announces That Glass Lewis and ISS Governance Services, the Leading Proxy Voting Advisory Services, Have Recommended Their Clients Vote against Kang-Korea Alcohol Nominees at the October 31 EGM
10/19/2007 12:12:47 PM
More...
|
Dong-A Pharmaceutical Co., Ltd. Calls on Kang-Korea Alcohol Nominees at October 31 EGM to Disclose Any Agreements or Understandings They Have Regarding Their Possible Service as Dong-A Pharmaceutical Co., Ltd. Directors
10/18/2007 3:16:36 PM
More...
|
Dong-A Pharmaceutical Co., Ltd. Exports Zydena, Its Erectile Dysfunction Drug, to Russia
10/16/2007 11:42:11 AM
More...
|
Dong-A Pharmaceutical Co., Ltd. Urges Shareholders to Vote against the Kang-Korea Alcohol Nominees at the October 31 EGM
10/12/2007 11:42:33 AM
More...
|
A Co-Development Contract Between Dong-A Pharmaceutical Co., Ltd. and Genexine Co. Ltd. as Win-Win Model to Prepare the International Competition After the FTA Between Korea and USA
6/13/2007 10:05:32 AM
More...
|
Former President and CEO of Dong-A Pharmaceutical Co., Ltd. Issues Letter to Investors Urging Voting Support for Dissident Group in Proxy Contest and Explaining Early Voting Cutoff Dates for Foreign Investors
3/16/2007 10:33:43 AM
More...
|
Dong-A Pharmaceutical Co., Ltd. Acquisition Of European COS Of An Active Anticancer Ingredient
1/24/2007 10:46:49 AM
More...
|
|